CS logo
small CS logo
Miami Cancer Institute

Miami, Florida, United States
Cancer treatment center in Kendall, Florida
8900 N Kendall Dr, Miami, FL 33176

About Miami Cancer Institute


"Baptist Health offers an extensive range of medical, surgical and technological services — including weight-loss surgery, pediatrics, addiction treatment and cancer care — provided by renowned physicians."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Children's Oncology Group
50
Memorial Sloan Kettering Cancer Center
24
National Cancer Institute (NCI)
23
Baptist Health South Florida
21
Radiation Therapy Oncology Group
19
Hoffmann-La Roche
8
NRG Oncology
8
Gilead Sciences
4
Incyte Corporation
4
Janssen Research & Development, LLC
4
Pfizer
4
Total Rows: 82

Clinical Trials at Miami Cancer Institute


During the past decade, Miami Cancer Institute conducted 170 clinical trials. In the 10-year time frame, 170 clinical trials started and 50 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 28 clinical trials were completed. i.e. 43.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66992727252538382424191918184444226655557712125544Started TrialsCompleted Trails20152016201720182019202020212022202302040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Surgery in Treating Children With Neuroblastoma
1998-03-01
2006-03-01
Completed
968
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
1998-12-01
2007-03-01
Completed
294
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
2000-04-01
Completed
838

Rows per page:

1–100 of 260

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Miami Cancer Institute" #1 sponsor was "Children's Oncology Group" with 50 trials, followed by "Memorial Sloan Kettering Cancer Center" with 24 trials sponsored, "National Cancer Institute (NCI)" with 23 trials sponsored, "Baptist Health South Florida" with 21 trials sponsored and "Radiation Therapy Oncology Group" with 21 trials sponsored. Other sponsors include 118 different institutions and companies that sponsored additional 82 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 75 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChildren's Oncology Group: 50Children's Oncology Group: 50Memorial SloanKettering CancerCenter: 24Memorial SloanKettering CancerCenter: 24National CancerInstitute (NCI): 23National CancerInstitute (NCI): 23Baptist Health South Florida: 21Baptist Health South Florida: 21Radiation TherapyOncology Group: 19Radiation TherapyOncology Group: 19Hoffmann-La Roche: 8Hoffmann-La Roche: 8NRG Oncology: 8NRG Oncology: 8Gilead Sciences: 4Gilead Sciences: 4Incyte Corporation: 4Incyte Corporation: 4Janssen Research &Development, LLC: 4Janssen Research &Development, LLC: 4

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 84National CancerInstitute (NCI): 84NRG Oncology: 17NRG Oncology: 17Merck Sharp & Dohme LLC: 6Merck Sharp & Dohme LLC: 6Bristol-Myers Squibb: 5Bristol-Myers Squibb: 5Cancer and LeukemiaGroup B: 5Cancer and LeukemiaGroup B: 5AstraZeneca: 4AstraZeneca: 4SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4Miami Cancer Institute: 3Miami Cancer Institute: 3North Central CancerTreatment Group: 3North Central CancerTreatment Group: 3NovoCure Ltd.: 3NovoCure Ltd.: 3

Clinical Trials Conditions at Miami Cancer Institute


According to Clinical.Site data, the most researched conditions in "Miami Cancer Institute" are "Breast Cancer" (10 trials), "Leukemia" (9 trials), "Lung Cancer" (9 trials), "Acute Lymphoblastic Leukemia" (8 trials) and "Glioblastoma" (7 trials). Many other conditions were trialed in "Miami Cancer Institute" in a lesser frequency.

Clinical Trials Intervention Types at Miami Cancer Institute


Most popular intervention types in "Miami Cancer Institute" are "Drug" (182 trials), "Radiation" (76 trials), "Other" (66 trials), "Biological" (47 trials) and "Procedure" (41 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Questionnaire Administration" (21 trials), "Radiation Therapy" (21 trials), "Cyclophosphamide" (19 trials) and "Quality-of-Life Assessment" (18 trials). Other intervention names were less common.

Clinical Trials Genders at Miami Cancer Institute


The vast majority of trials in "Miami Cancer Institute" are 229 trials for "All" genders, 19 trials for "Female" genders and 12 trials for "Male" genders.

Clinical Trials Status at Miami Cancer Institute


Currently, there are 170 active trials in "Miami Cancer Institute". 2 are not yet recruiting, 92 are recruiting, 75 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 67 completed trials in Miami Cancer Institute, 5 suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Miami Cancer Institute, 31 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 107Phase 2: 107Phase 3: 92Phase 3: 92Phase 1: 31Phase 1: 31Not Applicable: 17Not Applicable: 17Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusRecruiting: 92Recruiting: 92Active, not recruiting: 75Active, not recruiting: 75Completed: 67Completed: 67Terminated: 10Terminated: 10Suspended: 5Suspended: 5Unknown status: 3Unknown status: 3Withdrawn: 3Withdrawn: 3Available: 2Available: 2Not yet recruiting: 2Not yet recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1